You just read:

PENDOPHARM enters into an exclusive distribution agreement for the commercialisation rights to non-prescription Nasacort® Allergy 24HR (triamcinolone acetonide) in Canada

News provided by

Pharmascience Inc.

Jun 12, 2015, 07:10 ET